Simian virus 40 large T antigen contains two independent activities that cooperate with a ras oncogene to transform rat embryo fibroblasts.

PubWeight™: 1.05‹?› | Rank: Top 15%

🔗 View Article (PMC 188661)

Published in J Virol on February 01, 1995

Authors

J F Cavender1, A Conn, M Epler, H Lacko, M J Tevethia

Author Affiliations

1: Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey 17033.

Articles citing this

The amino-terminal transforming region of simian virus 40 large T and small t antigens functions as a J domain. Mol Cell Biol (1997) 2.33

T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol Mol Biol Rev (2002) 1.92

The Gal3p-Gal80p-Gal4p transcription switch of yeast: Gal3p destabilizes the Gal80p-Gal4p complex in response to galactose and ATP. Mol Cell Biol (1999) 1.30

p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J Virol (1997) 1.27

pRB-dependent, J domain-independent function of simian virus 40 large T antigen in override of p53 growth suppression. J Virol (2000) 1.03

A truncated T antigen expressed from an alternatively spliced BK virus early mRNA. J Gen Virol (2009) 1.02

A simian virus 40 large T-antigen segment containing amino acids 1 to 127 and expressed under the control of the rat elastase-1 promoter produces pancreatic acinar carcinomas in transgenic mice. J Virol (1997) 1.00

Cytotoxic T-lymphocyte epitope immunodominance in the control of choroid plexus tumors in simian virus 40 large T antigen transgenic mice. J Virol (1999) 0.96

Simian virus 40 large T antigen J domain and Rb-binding motif are sufficient to block apoptosis induced by growth factor withdrawal in a neural stem cell line. J Virol (1999) 0.94

Transcriptional control of SV40 T-antigen expression allows a complete reversion of immortalization. Nucleic Acids Res (2004) 0.93

ETS-1 and ETS-2 are upregulated in a transgenic mouse model of pigmented ocular neoplasm. Mol Vis (2008) 0.90

Adding an Rb-binding site to an N-terminally truncated simian virus 40 T antigen restores growth to high cell density, and the T common region in trans provides anchorage-independent growth and rapid growth in low serum concentrations. J Virol (1997) 0.88

CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors. J Immunol (2008) 0.86

Regions and activities of simian virus 40 T antigen that cooperate with an activated ras oncogene in transforming primary rat embryo fibroblasts. J Virol (2002) 0.86

Immortalized bovine pancreatic duct cells become tumorigenic after transfection with mutant k-ras. Virchows Arch (2001) 0.84

Transactivation of a ribosomal gene by simian virus 40 large-T antigen requires at least three activities of the protein. J Virol (1999) 0.83

Simian virus 40 large T antigen and two independent T-antigen segments sensitize cells to apoptosis following genotoxic damage. J Virol (2002) 0.83

Modification of a tumor antigen determinant to improve peptide/MHC stability is associated with increased immunogenicity and cross-priming a larger fraction of CD8+ T cells. J Immunol (2012) 0.83

Differential interaction of temperature-sensitive simian virus 40 T antigens with tumor suppressors pRb and p53. J Virol (1996) 0.82

A structure-guided mutational analysis of simian virus 40 large T antigen: identification of surface residues required for viral replication and transformation. J Virol (2009) 0.80

Transactivation of E2F-regulated genes by polyomavirus large T antigen: evidence for a two-step mechanism. Mol Cell Biol (2004) 0.76

Anaplastic renal carcinoma expressing SV40 T antigen in a female TRAMP mouse. Comp Med (2013) 0.76

Articles cited by this

DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A (1977) 790.54

Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Mol Appl Genet (1982) 54.79

ras genes. Annu Rev Biochem (1987) 22.59

Enchancement of the infectivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-dextran. J Natl Cancer Inst (1968) 21.44

T antigen is bound to a host protein in SV40-transformed cells. Nature (1979) 17.78

Monoclonal antibodies specific for simian virus 40 tumor antigens. J Virol (1981) 15.59

SR alpha promoter: an efficient and versatile mammalian cDNA expression system composed of the simian virus 40 early promoter and the R-U5 segment of human T-cell leukemia virus type 1 long terminal repeat. Mol Cell Biol (1988) 12.84

The arrangement of simian virus 40 sequences in the DNA of transformed cells. Cell (1976) 12.60

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents. Cell (1993) 12.02

The p53 proto-oncogene can act as a suppressor of transformation. Cell (1989) 11.67

Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture. Nature (1983) 11.61

General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes. J Virol (1984) 10.98

Adenovirus E1b-58kd tumor antigen and SV40 large tumor antigen are physically associated with the same 54 kd cellular protein in transformed cells. Cell (1982) 9.27

Presence of a potent transcription activating sequence in the p53 protein. Science (1990) 6.38

Activating mutations in p53 produce a common conformational effect. A monoclonal antibody specific for the mutant form. EMBO J (1990) 6.34

Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev (1993) 6.02

Post-translational regulation of the 54K cellular tumor antigen in normal and transformed cells. Mol Cell Biol (1981) 6.02

Non-producer human cells induced by murine sarcoma virus. Int J Cancer (1975) 5.82

Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene. Science (1990) 5.47

The adenovirus E1A proteins induce apoptosis, which is inhibited by the E1B 19-kDa and Bcl-2 proteins. Proc Natl Acad Sci U S A (1992) 5.43

Mutants of SV40 with an altered small t protein are reduced in their ability to transform cells. Cell (1978) 5.23

p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol (1990) 5.20

Growth regulation of a cellular tumour antigen, p53, in nontransformed cells. Nature (1984) 4.86

Monensin inhibits the processing of herpes simplex virus glycoproteins, their transport to the cell surface, and the egress of virions from infected cells. J Virol (1982) 4.74

The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell (1989) 4.48

Isolation and preliminary characterization of a human transforming gene from T24 bladder carcinoma cells. Nature (1982) 4.30

Normal rat cell lines deficient in nuclear thymidine kinase. Virology (1981) 4.13

Wild-type p53 binds to the TATA-binding protein and represses transcription. Proc Natl Acad Sci U S A (1992) 4.06

In vitro mutagenesis of a putative DNA binding domain of SV40 large-T. Virology (1984) 3.50

p53 and DNA polymerase alpha compete for binding to SV40 T antigen. Nature (1987) 3.34

T-antigen-DNA polymerase alpha complex implicated in simian virus 40 DNA replication. Mol Cell Biol (1986) 3.22

Effect of cell chromosome number on simian virus 40 replication. Exp Cell Res (1973) 3.20

SV40 T antigen binds directly to the large subunit of purified DNA polymerase alpha. EMBO J (1990) 2.65

Specific repression of TATA-mediated but not initiator-mediated transcription by wild-type p53. Nature (1993) 2.61

Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. Nucleic Acids Res (1984) 2.28

SV40 small t antigen enhances the transformation activity of limiting concentrations of SV40 large T antigen. Cell (1987) 2.13

Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J Virol (1993) 2.02

The large tumor antigen of simian virus 40 encodes at least two distinct transforming functions. J Virol (1989) 2.00

Localization of the E1B proteins of adenovirus 5 in transformed cells, as revealed by interaction with monoclonal antibodies. Virology (1985) 1.94

Adenovirus serotype determines association and localization of the large E1B tumor antigen with cellular tumor antigen p53 in transformed cells. Mol Cell Biol (1985) 1.91

Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol Cell Biol (1991) 1.85

Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. Virology (1990) 1.77

Transcriptional activation by simian virus 40 large T antigen: interactions with multiple components of the transcription complex. Mol Cell Biol (1993) 1.73

Expression and complex formation of simian virus 40 large T antigen and mouse p53 in insect cells. J Virol (1988) 1.72

Identification of a human cytomegalovirus virus DNA segment that complements an adenovirus 5 immediate early mutant. Virology (1986) 1.57

Characterization of mutant p53-hsp72/73 protein-protein complexes by transient expression in monkey COS cells. Mol Cell Biol (1988) 1.48

Kinetics of expression of herpes simplex virus type 1-specific glycoprotein species on the surfaces of infected murine, simian, and human cells: flow cytometric analysis. J Virol (1987) 1.46

The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53. J Virol (1991) 1.46

Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen. Proc Natl Acad Sci U S A (1990) 1.39

Requirements for immortalization of primary mouse embryo fibroblasts probed with mutants bearing deletions in the 3' end of SV40 gene A. Virology (1988) 1.37

Activated Ha-ras can cooperate with defective simian virus 40 in the transformation of nonestablished rat embryo fibroblasts. J Virol (1987) 1.36

SV40 T antigen abrogates p53-mediated transcriptional activity. Oncogene (1993) 1.31

Two separable functional domains of simian virus 40 large T antigen: carboxyl-terminal region of simian virus 40 large T antigen is required for efficient capsid protein synthesis. J Virol (1985) 1.31

Sequences from polyomavirus and simian virus 40 large T genes capable of immortalizing primary rat embryo fibroblasts. J Virol (1985) 1.31

Adenovirus transcription. II. RNA sequences complementary to simian virus 40 and adenovirus 2DNA in AD2+ND1- and AD2+ND3-infected cells. J Virol (1975) 1.28

Immortalization of primary mouse embryo fibroblasts with SV40 virions, viral DNA, and a subgenomic DNA fragment in a quantitative assay. Virology (1984) 1.24

The amino-terminal functions of the simian virus 40 large T antigen are required to overcome wild-type p53-mediated growth arrest of cells. J Virol (1994) 1.22

The kinetics of simian virus 40-induced progression of quiescent cells into S phase depend on four independent functions of large T antigen. J Virol (1994) 1.22

Simian virus 40 deletion mutants that transform with reduced efficiency. Mol Cell Biol (1983) 1.12

Cooperation of SV40 large T antigen and the cellular protein p53 in maintenance of cell transformation. Oncogene (1989) 1.04

The amino-terminal 147 amino acids of SV40 large T antigen transform secondary rat embryo fibroblasts. Virology (1991) 1.01

Stable T-p53 complexes are not required for replication of simian virus 40 in culture or for enhanced phosphorylation of T antigen and p53. J Virol (1991) 1.00

Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants. J Virol (1988) 0.98

Large E1B proteins of adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol (1993) 0.95

Stabilization of the tumor suppressor p53 during cellular transformation by simian virus 40: influence of viral and cellular factors and biological consequences. J Virol (1994) 0.95

Biochemical properties of the growth suppressor/oncoprotein p53. Oncogene (1992) 0.88

An SV40 mutant oncoprotein has a nuclear location. Virology (1989) 0.83

Articles by these authors

Demonstration of high-fidelity simulation team training for emergency medicine. Acad Emerg Med (1999) 2.82

DNA binding properties of simian virus 40 temperature-sensitive A proteins. J Virol (1982) 2.31

Recombination between temperature-sensitive mutants of herpes simplex virus type 1. Virology (1974) 2.12

Association of p53 binding and immortalization of primary C57BL/6 mouse embryo fibroblasts by using simian virus 40 T-antigen mutants bearing internal overlapping deletion mutations. J Virol (1993) 2.02

Dissociation of Rb-binding and anchorage-independent growth from immortalization and tumorigenicity using SV40 mutants producing N-terminally truncated large T antigens. Virology (1990) 1.77

Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169. Virology (1981) 1.71

Protein-protein interactions between human cytomegalovirus IE2-580aa and pUL84 in lytically infected cells. J Virol (1994) 1.62

Nature of the ethylenediaminetetraacetic acid requirement for transformation of Bacillus subtilis with single-stranded deoxyribonucleic acid. J Bacteriol (1970) 1.58

Identification of a human cytomegalovirus virus DNA segment that complements an adenovirus 5 immediate early mutant. Virology (1986) 1.57

Characterization of a temperature-sensitive, DNA-positive, nontransforming mutant of simian virus 40. Virology (1981) 1.53

Bacteriophage T5 chromosome fractionation: genetic specificity of a DNA fragment. Science (1966) 1.48

Rat alpha 1-acid glycoprotein mRNA. Cloning of double-stranded cDNA and kinetics of induction of mRNA levels following acute inflammation. J Biol Chem (1981) 1.47

Quantitation of CD8(+) T-lymphocyte responses to multiple epitopes from simian virus 40 (SV40) large T antigen in C57BL/6 mice immunized with SV40, SV40 T-antigen-transformed cells, or vaccinia virus recombinants expressing full-length T antigen or epitope minigenes. J Virol (2000) 1.31

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IX. Analysis of TrAg in mouse cells synthesizing truncated SV40 large T antigen. Virology (1983) 1.28

p300 family members associate with the carboxyl terminus of simian virus 40 large tumor antigen. J Virol (1997) 1.27

Immortalization of primary mouse embryo fibroblasts with SV40 virions, viral DNA, and a subgenomic DNA fragment in a quantitative assay. Virology (1984) 1.24

The effect of supervision of residents on quality of care in five university-affiliated emergency departments. Acad Med (1998) 1.15

Benchmarking and quality improvement: the Harvard Emergency Department Quality Study. Am J Med (1999) 1.13

Complementation of an adenovirus 5 immediate early mutant by human cytomegalovirus. Virology (1984) 1.11

Clustering of antigenic sites recognized by cytotoxic T lymphocyte clones in the amino terminal half of SV40 T antigen. Virology (1988) 1.10

Temperature-sensitive mutants identify crucial structural regions of simian virus 40 large T antigen. J Virol (1989) 1.09

Cytotoxic T lymphocytes (CTL) against a transforming gene product select for transformed cells with point mutations within sequences encoding CTL recognition epitopes. J Exp Med (1992) 1.07

SV40 transplantation antigen: relationship to SV40-specific proteins. Cold Spring Harb Symp Quant Biol (1980) 1.07

Pleiotropic effects of suppressor mutations in Bacillus subtilis. J Bacteriol (1974) 1.07

The human cytomegalovirus 86-kilodalton immediate-early 2 protein: synthesis as a precursor polypeptide and interaction with a 75-kilodalton protein of probable viral origin. J Virol (1994) 0.99

Nonselective expression of simian virus 40 large tumor antigen fragments in mouse cells. Proc Natl Acad Sci U S A (1982) 0.99

Fine mapping two distinct antigenic sites on simian virus 40 (SV40) T antigen reactive with SV40-specific cytotoxic T-cell clones by using SV40 deletion mutants. J Virol (1988) 0.98

Mice with spontaneous pancreatic cancer naturally develop MUC-1-specific CTLs that eradicate tumors when adoptively transferred. J Immunol (2000) 0.98

Biology of simian virus 40 (SV40) transplantation antigen (TrAg) II. Isolation and characterization of additional temperature-sensitive mutants of SV40. Virology (1977) 0.97

Simian virus 40 T antigen as a carrier for the expression of cytotoxic T-lymphocyte recognition epitopes. J Virol (1993) 0.96

Cytotoxic T lymphocyte escape variants, induced mutations, and synthetic peptides define a dominant H-2Kb-restricted determinant in simian virus 40 tumor antigen. Virology (1995) 0.94

Objective evaluation of peroneal response to sudden inversion stress. J Orthop Sports Phys Ther (1985) 0.93

Identification of a variable region at the carboxy terminus of SV40 large T-antigen. Virology (1996) 0.91

A simple qualitative spot complementation test for temperature-sensitive mutants of SV40. Intervirology (1974) 0.90

Altered proteins with triosephosphate isomerase activity in suppressor-containing strains of Bacillus subtilis. J Bacteriol (1974) 0.89

Influence of amino acids encoded in the 3' open reading frame of the SV40 early region on transformation and antigenicity of large T antigen. Virology (1986) 0.89

Transformation of isolated rat hepatocytes with simian virus 40. J Cell Biol (1980) 0.88

Biology of SV40 transplantation antigen (TrAg). I. Demonstration of SV40 TrAg on glutaraldehyde-fixed SV40-infected African green monkey kidney cells. Virology (1976) 0.87

Simian virus 40 specific cytotoxic lymphocyte clones localize two distinct TSTA sites on cells synthesizing a 48 kD SV40 T antigen. Virology (1984) 0.87

Tumorigenicity of simian virus 40-transformed rat hepatocytes. Cancer Res (1981) 0.86

Abrogation of simian virus 40 DNA-mediated transformation of primary C57BL/6 mouse embryo fibroblasts by exposure to a simian virus 40-specific cytotoxic T-lymphocyte clone. J Virol (1985) 0.86

Recognition of simian virus 40 T antigen synthesized during viral lytic cycle in monkey kidney cells expressing mouse H-2Kb- and H-2Db-transfected genes by SV40-specific cytotoxic T lymphocytes leads to the abrogation of virus lytic cycle. Virology (1988) 0.85

Heterologous transactivation among viruses. Prog Med Virol (1989) 0.85

Two regions of simian virus 40 large T-antigen independently extend the life span of primary C57BL/6 mouse embryo fibroblasts and cooperate in immortalization. Virology (1998) 0.85

A novel translational regulation function for the simian virus 40 large-T antigen gene. J Virol (1995) 0.85

Transcription of the aligned chromosome of Bacillus subtilis W23. Proc Natl Acad Sci U S A (1967) 0.84

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). VII. Induction of SV40 TrAg in nonpermissive mouse cells by early viable SV40 deletion (o.54/0.59) mutants. Virology (1980) 0.84

Simian virus 40 large T antigen and two independent T-antigen segments sensitize cells to apoptosis following genotoxic damage. J Virol (2002) 0.83

Transactivation of a ribosomal gene by simian virus 40 large-T antigen requires at least three activities of the protein. J Virol (1999) 0.83

In vivo release of neurotransmitters in the medial basal hypothalamus of the monkey. Exp Brain Res (1984) 0.82

Cytotoxic T lymphocyte recognition sequences as markers for distinguishing among tumour antigens encoded by SV40, BKV and JCV. Dev Biol Stand (1998) 0.82

Antibody response to human papovavirus JC (JCV) and simian virus 40 (SV40) T antigens in SV40 T antigen-transgenic mice. Virology (1992) 0.82

Biology of simian virus 40 (SV40) transplantation antigen (TrAg) III. Involvement of SV40 gene A in the expression of TrAg in permissive cells. Virology (1977) 0.81

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). X. Tumorigenic potential of mouse cells transformed by SV40 in high responder C57BL/6 mice and correlation with the persistence of SV40 TrAg, early proteins and sequences. Virology (1983) 0.80

Effects of pH on transformation of Bacillus subtilis with single-stranded deoxyribonucleic acid. J Bacteriol (1971) 0.80

Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein. Virology (1996) 0.80

Immune response of athymic nude mice to papovavirus SV40 tumor-associated antigens. Int J Cancer (1977) 0.80

Localization of common cytotoxic T lymphocyte recognition epitopes on simian papovavirus SV40 and human papovavirus JC virus T antigens. Virology (1991) 0.79

Cell-mediated immunity to virus-induced tumors: generation of lymphocytes sensitized to specific transplantation antigen in mouse cells infected with papovavirus SV40. Prog Med Virol (1975) 0.78

Hypomagnesemia is a frequent finding in the emergency department in patients with chest pain. Arch Intern Med (1991) 0.78

Relationship between competence for transformation of Bacillus subtilis with native and single-stranded deoxyribonucleic acid. J Bacteriol (1971) 0.77

Effect of the AirStirrup in Controlling Ankle Inversion Stress. J Orthop Sports Phys Ther (1987) 0.77

Role of CTL host responses and their implication for tumorigenicity testing and the use of tumour cells as vaccine substrate. Dev Biol (Basel) (2001) 0.77

Effect of standard and Aircast tennis elbow bands on integrated electromyography of forearm extensor musculature proximal to the bands. Am J Sports Med (1989) 0.76

Mapping of additional temperature-sensitive mutations (1600 series) on the genome of simian virus 40 by marker rescue. Virology (1981) 0.76

Cytotoxic T-lymphocyte recognition of simian virus 40 antigens. Cancer Surv (1985) 0.76

Near drowning and hypothermia mimicking severe closed head injury. Br Med J (Clin Res Ed) (1986) 0.75

A rapid method for comparative quantitative polymerase chain reaction of HIV-1 proviral DNA extracted from cryopreserved brain tissues. J Virol Methods (1997) 0.75

The effect of severe trauma on urinary cyclic AMP in children of different ages. Clin Chim Acta (1976) 0.75

Significance of specific transplantation antigen expression at the surface of papovavirus SV40-infected permissive cells. Bibl Haematol (1975) 0.75

Properties of simian virus 40 (SV40)-transformed hepatocytes. Ann N Y Acad Sci (1980) 0.75

Biology of simian virus 40 (SV40) transplantation antigen (TrAg). IV. Inhibition by human interferon of expression of SV40 TrAg in SV40-infected monkey cells. Virology (1979) 0.75

Continuing education through participation--a rewarding approach. Ont Dent (1981) 0.75

Urinary cyclic AMP and post-traumatic acute renal failure. Clin Chim Acta (1977) 0.75

Effect of oral digoxin, topical ouabain and salbutamol on transepithelial nasal potential difference in patients with cystic fibrosis. Clin Sci (Lond) (1995) 0.75

Molecular dissection of mhc complex and of sv40-induced surface antigen. Ann N Y Acad Sci (1982) 0.75

Operating room. Skilled teams, immediate treatment save lives in Baltimore trauma/shock unit. Hosp Top (1975) 0.75